Systemic inflammation and progression of COPD

Thorax

Volumn 62, Issue 6, 2007, Pages 469-470

  Vestbo, Jørgen ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA BASE; DISEASE COURSE; EDITORIAL; EXPIRATORY RESERVE VOLUME; HEART INJURY; HEPATITIS C; HUMAN; INFLAMMATION; LUNG PARENCHYMA; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; UNDERWEIGHT;

C-REACTIVE PROTEIN; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34250328667     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.077792     Document Type: Editorial

References (16)

1. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80.
2. Man SFP, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-53.
3. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in COPD. Am J Respir Crit Care Med 2007;175:250-5.
4. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? Circulation 2003;107:1514-9.
5. Fogarty AW, Jones S, Britton JR, et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007;62:515-20.
6. 1 decline: a longitudinal population-based study. Respir Med 2006;100:2112-20.
7. Dahl M, Tybjærg-Hansen A, Vestbo J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1008-11.
8. Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients. Chest 2003;123:596-9.
9. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
10. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
11. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat free body mass and prognosis in COPD patients from a random population sample. Am J Respir Crit Care Med 2006;173:79-83.
12. De Godoy I, Donahoe M, Calhoun WJ, et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996;153:633-7.
13. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factor alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150:1453-5.
14. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-8.
15. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-93.
16. Agusti AGN. COPD, a multicomponent disease: implications for management. Respir Med 2005;99:670-82.